Insurance Rachel Cohrs Zhang STAT Plus: Medicare couldn’t cover Wegovy for weight loss. But now that it’s also a heart drug, the door is open
Business Brittany Trang STAT Plus: Medicare announces loan program to aid providers affected by Change cyberattack
Politics Rachel Cohrs Zhang STAT Plus: Pharma giants, government spar in court over Medicare drug price negotiation
Business Brittany Trang STAT Plus: Nursing home owners can hide nearly two-thirds of their profits, new study shows
Politics Rachel Cohrs Zhang STAT Plus: Biden to propose expanding Medicare drug price negotiation in State of the Union
Health tech Mario Aguilar STAT Plus: Medicare is a tricky market for telehealth companies. Why is Talkspace betting on it?
Politics John Wilkerson and Rachel Cohrs Zhang STAT Plus: Congress gives doctors Medicare pay bump, sets up December fight in new funding package
Politics Rachel Cohrs Zhang STAT Plus: Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation
First Opinion Samyukta Mullangi New federal guidance is hurting cancer patients, especially those in rural areas
Exclusive Lizzy Lawrence STAT Plus: Medical device lobby says it’s tired of waiting on Medicare to cover breakthrough devices
Politics Nicholas Florko STAT Plus: Why won’t Medicare deliver food to sick seniors, if it could get them healthy?
First Opinion Wendell Potter and Philip Verhoef Medicare Advantage is bad for patients and bad for investors
First Opinion Rachel M. Werner New CMS rules will throttle access researchers need to Medicare, Medicaid data
The Readout LOUD Damian Garde, Allison DeAngelis, and Adam Feuerstein Listen: Pharma goes to Washington, Alnylam’s future, & Gilead’s dealmaking